Anthony Lorenzo U.S. FDA
Anthony Lorenzo U.S. FDA Branch Chief, OCBQ, CBER
Mr. Lorenzo has been with the FDA since March 2010 in the Office of Compliance and Biologics Quality (OCBQ), Division of' Manufacturing and Product Quality (DMPQ), Manufacturing Branch 2 (MRB 2), Center for Biologics Evaluation and Research (CBER). Prior to joining the Agency, he had 20 years of experience in CGMP manufacturing; designing, building, commissioning, and validating biologic manufacturing facilities; and scaling up pilot scale to large scale manufacturing. Today, Mr. Lorenzo is the Chief for Manufacturing Review Branch 2 (MRB2) responsible for planning, coordinating, and evaluating the overall review and approval process for BLAs and supplements in the branch.